Որոնում (Նորություններ)

Unicycive Therapeutics Receives FDA Complete Response Letter for Oxylanthanum Carbonate NDA

english business

FDA did not raise concerns regarding the clinical efficacy or safety data of OLC, and no additional data was requested
2026-07-01 00:00:00